Publication

The Bcl9-beta-catenin interface as a potential therapeutic target for colorectal cancer

Related publications (112)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

The Bcl9-beta-catenin interface as a potential therapeutic target for colorectal cancer

Graph Chatbot

Chat with Graph Search

Regulation and function of a hemicleaved Activin-A processing intermediate in melanoma

Neurogenesis redirects β-catenin from adherens junctions to the nucleus to promote axonal growth

Gallocin A, an Atypical Two-Peptide Bacteriocin with Intramolecular Disulfide Bonds Required for Activity

Apelin-driven endothelial cell migration sustains intestinal progenitor cells and tumor growth

Immunosuppressive roles of Activin-A in melanoma and characterization of its precursor cleavage

High-content, targeted RNA-seq screening in organoids for drug discovery in colorectal cancer

Next-generation cancer organoids

Roles of Epigenetic Dysregulation in Cancer Progression and Metastasis

Patient‐specific logic models of signaling pathways from screenings on cancer biopsies to prioritize personalized combination therapies

TBX3 acts as tissue-specific component of the Wnt/beta-catenin transcriptional complex